Use of health-related quality of life in prescribing research. Part 1: why evaluate health-related quality of life?

被引：74

作者：

Calvert, MJ ^{[1
]}

Freemantle, N ^{[1
]}

机构：

[1] Univ Birmingham, Dept Primary Care & Gen Practice, Birmingham B15 2TT, W Midlands, England

来源：

JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS | 2003年 / 28卷 / 06期

关键词：

chronic disease; clinical practice; health policy; health-related quality of life; licensing;

D O I：

10.1046/j.0269-4727.2003.00521.x

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Clinicians, regulatory authorities, and pharmaceutical companies increasingly recognize the importance of assessing the patient's perspective on the impact of disease and its treatment on their health-related quality of life (HRQoL). This article describes the importance of assessing HRQoL, particularly in patients with chronic disease, provides examples of the different types of instrument available for measuring HRQoL and considers how such assessment can aid medical-decision making. In addition we consider the potential role of HRQoL assessment in routine clinical practice, and its use in licensing and health technology appraisal.

引用

页码：513 / 521

页数：9

共 53 条

[1] THE EUROPEAN-ORGANIZATION-FOR-RESEARCH-AND-TREATMENT-OF-CANCER QLQ-C30 - A QUALITY-OF-LIFE INSTRUMENT FOR USE IN INTERNATIONAL CLINICAL-TRIALS IN ONCOLOGY [J].

AARONSON, NK ;

AHMEDZAI, S ;

BERGMAN, B ;

BULLINGER, M ;

CULL, A ;

DUEZ, NJ ;

FILIBERTI, A ;

FLECHTNER, H ;

FLEISHMAN, SB ;

DEHAES, JCJM ;

KAASA, S ;

KLEE, M ;

OSOBA, D ;

RAZAVI, D ;

ROFE, PB ;

SCHRAUB, S ;

SNEEUW, K ;

SULLIVAN, M ;

TAKEDA, F .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1993, 85 (05) :365-376

[2] Self-rating of quality of life provides additional prognostic information in heart failure.: Insights into the EPICAL study [J].

Alla, F ;

Briançon, S ;

Guillemin, F ;

Juillière, Y ;

Mertès, PM ;

Villemot, JP ;

Zannad, F .

EUROPEAN JOURNAL OF HEART FAILURE, 2002, 4 (03) :337-343

[3]

Altman D, 1993, PRACTICAL STAT MED R

[4]

[Anonymous], 2002, ONEILL REV

[5]

[Anonymous], 2003, DIET NUTR

Apolone, G ;

De Carli, G ;

Brunetti, M ;

Garattini, S .

PHARMACOECONOMICS, 2001, 19 (02) :187-195

[7] The importance of health-related quality-of-life data in determining the value of drug therapy [J].

Badia, X ;

Herdman, M .

CLINICAL THERAPEUTICS, 2001, 23 (01) :168-175

[8]

Barrett Bruce, 2002, J Fam Pract, V51, P265

[9]

BECK AT, 1984, J CLIN PSYCHOL, V40, P1365, DOI 10.1002/1097-4679(198411)40:6<1365::AID-JCLP2270400615>3.0.CO

[10]

2-D

← 1 2 3 4 5 6 →